| Line item | 2025-07-31 FY | 2024-07-31 FY | 2023-07-31 FY | 2022-07-31 FY | 2021-07-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $322.00K | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | $82.05K | – | – | – |
| Operating Expenses | $4.80M | $1.07M | $961.57K | $1.14M | $1.27M |
| R&D | – | – | – | – | – |
| SG&A | $2.76M | $516.28K | $674.55K | $1.14M | $1.27M |
| Operating Income | -$4.80M | -$983.56K | -$961.57K | -$1.14M | -$1.27M |
| Interest Expense | – | – | $417.34K | $447.62K | $227.90K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$4.64M | -$702.49K | -$1.30M | -$1.36M | -$1.46M |
| EPS (basic) | -0.0400 | -0.0100 | -0.0300 | -0.0300 | -0.0400 |
| EPS (diluted) | -0.0400 | -0.0100 | -0.0300 | -0.0300 | – |
| Shares (diluted) | $130.93M | $70.05M | $44.05M | $42.02M | – |